Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02257853 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients

A Phase 2 study of Stress, Psychological and Caregivers, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
Phase 2
Development phase
53
Enrollment target
1
Study location

NCT02257853 is a Phase 2 study of Stress, Psychological and Caregivers that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 53 participants, below the 171-participant average among 43 other Stress, Psychological trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02257853, a Phase 2 study of Stress, Psychological and Caregivers, has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
Phase 2
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

Background: \- People who have an allogeneic hematopoietic stem cell transplant (HSCT) need help as they recover. Being a caregiver can be stressful to the body and mind. Researchers want to find ways to reduce this stress. Objective: \- To see how a stress reduction intervention affects the stress levels and health of an HSCT caregiver. Eligibility: \- Adults age 18 and older who plan to be an active caregiver for a person having their first allogeneic HSCT at the NIH Clinical Center. An active caregiver is someone who will be caring for the person from just before admission for the HSCT until at least 6 weeks after. Design: * Participants will be put in either the intervention group or the control group. * All participants will get the usual caregiver education given to all patients and caregivers having a stem cell transplant at the NIH Clinical Center. * All participants will have 2 study visits. They will give blood samples. They will have health assessments and brief physical exams. They will fill out study questionnaires and have an exit interview. * The intervention group will get an MP3 player. It will have an audio file with a stress reduction intervention on it. Participants will do this intervention daily. It takes 20 minutes. They will do gentle stretches and breathing exercises. They will get a diary to track their practice. * The intervention group also will have follow-up phone calls 2 and 4 weeks after their first clinic visit. * The person getting the HSCT will not be actively involved in the study. * The study will last about 2 months.

Interventions

  • OTHER Stress reduction intervention

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2015-01-05
Est. Completion 2019-02-07
Phase Phase 2

What the Registry Record Tells You About NCT02257853

The ClinicalTrials.gov registry entry for NCT02257853 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 171-participant average among 43 other Stress, Psychological trials with a reported enrollment target (69% lower). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stress, Psychological appearing as the primary indexed condition, and to 1 intervention - of which Stress reduction intervention is the first listed.

NCT02257853 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02257853 about?

NCT02257853 is a clinical study titled "Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients". Background: \- People who have an allogeneic hematopoietic stem cell transplant (HSCT) need help as they recover. Being a caregiver can be stressful to the body and mind. Researchers want to find ways to reduce this stress. Objective: \- To see how a stress reduction intervention affects the stre...

What is the current status of trial NCT02257853?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2015-01-05. Estimated completion is 2019-02-07.

What conditions does trial NCT02257853 study?

This clinical trial studies the following conditions: Stress, Psychological, Caregivers.

What interventions are being tested in trial NCT02257853?

The interventions under investigation include: Stress reduction intervention (OTHER).

Who is sponsoring clinical trial NCT02257853?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02257853 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress, Psychological

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.